The top 10 orthopedic device companies: financial performance, research
activities, and growth strategies
We no longer supply this report
The orthopedic device industry is highly competitive and has reached
maturity, as demonstrated by its single digit growth rate. The industry
is driven largely by incremental innovation and breakthrough product
launches have stalled. Several product lines are also facing severe
commoditization due to increased competition. Despite such high levels
of competition, the top 15 companies accounted for 95% of the market in
2009. The largest device segments are spinal, knee, and hip implants.
The fastest growing segment is orthobiologics.
The report provides detailed profiles of the top 10 orthopedic device
companies and brief profiles of five other major players. It elucidates
trends associated with companies that develop, manufacture, and market
orthopedic devices. Detailed profiles contain descriptions of products,
financial performance, and growth strategies together with SWOT
analyses. For each company analysis is based on:
- Each company's consolidated and segmental financial performance;
- Each company's growth strategies and major acquisitions and
divestments relating to the CV devices market;
- Key partnerships
and alliances formed by these companies; and
- Business-related
strengths and weaknesses of these companies, and insights into the
opportunities and threats facing them.
Key drivers and resistors to growth of leading CV device companies.
Drivers
- Demographics - aging population;
- Preference for biologic
implants increasing;
- Growth in emerging markets;
- Physician
preferences boosted by CME programs; and
- Continued innovation.
Resistors
- Increasing pricing pressure from buyers and payers;
- Rising
usage of comparative efficacy and health economics data;
- Regulatory
demand for postmarketing surveillance;
- Review of the PMN pathway in
the US; and
- Medical device excise tax amounting to $20bn over the next
20 years
Key benefits of reading this report
- Learn from the business operation strategies of the
premier orthopedic device companies to target future growth markets
effectively, avoid their mistakes, and replicate their successes.
- Benchmark your performance against the leading orthopedic
device companies.
- Analyze the growth strategies of major players in the
orthopedic industry and learn how their business models are planned
for the next 3 to 5 years.
- Compare performances of the top10 companies in the orthopedic
market with respect to acquisitions, new product innovation,
geography expansion, and industry challenges.
- Save time,
money, and resources on analyzing the performance of leading orthopedic device companies using this report.
Key questions answered by this report
- What was the market value of the global orthopedic device
industry in 2009?
- What are the global market values for the
major orthopedic device segments?
- What are the key trends
observed in the orthopedic device companies and what are the
strategic responses that are taking shape?
- Who are the major
players in the global orthopedic device market?
- What are the
growth strategies of the leading orthopedic device companies?
- What are the strengths, weaknesses, opportunities and threats faced
by the top 10 players?
Title Index:
Chapter 1 Introduction
- What is this report about?
- Methodology
Chapter 2 Industry overview
- Summary
- Introduction
- Market segmentation
- Competitive landscape
- Key drivers and
resistors
- Key events and trends
- Changes in the PMN pathway
will increase regulatory burden
- CME platforms will continue to
drive growth despite the Department of Justice (DOJ) clampdown
- CME
and inducements
- DOJ settlement with device manufacturers
- Physician Sunshine Act may stifle innovation in the orthopedic device
industry
- Impact of decline in hospital capital expenditure on orthopedics minimal in the near term
- Medical device industry
bracing for the comparative effectiveness research (CER) era
- Medical device excise tax will influence orthopedic market top line
- Rising regulatory pressure on spinal device makers
Chapter 3 Stryker
- Summary
- Company overview
- Marketed
products
- Orthopedic implants
- MedSurg equipment
- Financial performance
- Orthopedic implants
- Hip implant
systems
- Knee implant systems
- Trauma implant systems
- Spinal implant systems
- Craniomaxillofacial implant systems
- MedSurg equipments
- Surgical equipment and surgical navigation
systems
- Endoscopic and communications systems
- Research and
innovation
- Growth strategy
- SWOT
Chapter 4 DePuy
- Summary
- Company overview
- Marketed
products
- DePuy Orthopedics
- DePuy Spine
- DePuy Mitek
- Codman & Shurtleff
- Financial performance
- Research and
product launches
- Growth strategy
- SWOT
Chapter 5 Zimmer
- Summary
- Company overview
- Marketed
products
- Reconstructive
- Dental
- Trauma
- Spine
- OSP
- Financial performance
- Reconstructive
- Knee
- Hip
- Extremities
- Dental
- Trauma
- Spine
- OSP
- Research and innovation
- Growth strategy
- SWOT
Chapter 6 Medtronic
- Summary
- Company overview
- Marketed products
- Financial performance
- Core spinal
- Biologics
- Research and innovation
- Growth strategy
- SWOT
Chapter 7 Synthes
- Summary
- Company overview
- Marketed
products
- Trauma
- Spine
- CMF
- Financial performance
- Research and innovation
- Growth strategy
- SWOT
Chapter 8 Smith & Nephew
- Summary
- Company overview
- Marketed products
- Orthopedics
- Endoscopy
- Financial
performance
- Orthopedics
- Endoscopy
- Research and
innovation
- Growth strategy
- SWOT
Chapter 9 Biomet
- Summary
- Company overview
- Marketed
products
- Reconstructive products
- Fixation devices
- Spinal products
- Other
- Financial performance
- Research
and innovation
- Growth strategy
- SWOT
Chapter 10 Orthofix
- Summary
- Company overview
- Marketed products
- Spinal products
- Orthopedic products
- Sports medicine
- Financial performance
- Spine
- Orthopedics
- Sports medicine
- Research and innovation
- Growth strategies
- SWOT
Chapter 11 Wright Medical Group
- Summary
- Company overview
- Marketed products
- Hip products
- Knee products
- Extremity products
- Biologics products
- Financial performance
- Hip products
- Knee products
- Extremity products
- Biologic products
- Research and innovation
- Growth strategy
- SWOT
Chapter 12 Conmed
- Summary
- Company overview
- Marketed
products
- Arthroscopy
- Powered surgical instruments
- Fnancial performance
- Arthroscopy
- Powered surgical
equipments
- Research and innovation
- Growth strategy
- SWOT
Chapter 13 Other major companies
- NuVasive
- Integra LifeSciences
- Arthrocare
- Exactech
- RTI Biologics
- Appendix
- Abbreviations
Pricing:
Electronic (Single User) : EUR 2,812 Hard Copy : EUR 2,885
Electronic (Enterprisewide) : EUR 10,545
To top
|
|
|